BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Est. Return 108.35%
This Quarter Est. Return
1 Year Est. Return
+108.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.04B
AUM Growth
+$139M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
72
New
Increased
Reduced
Closed

Top Buys

1 +$23.9M
2 +$21.3M
3 +$12.7M
4
QURE icon
uniQure
QURE
+$11M
5
APGE icon
Apogee Therapeutics
APGE
+$10.5M

Top Sells

1 +$11.4M
2 +$8.97M
3 +$7.13M
4
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
+$7.08M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$2.85M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRK icon
51
Scholar Rock
SRRK
$2.69B
$6.01M 0.29%
+750,000
PSTX
52
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$5.72M 0.28%
2,000,000
-2,475,000
SMMT icon
53
Summit Therapeutics
SMMT
$15.6B
$5.47M 0.27%
+250,000
ENGN icon
54
enGene Holdings
ENGN
$479M
$4.8M 0.24%
727,900
PRLD icon
55
Prelude Therapeutics
PRLD
$67.4M
$3.54M 0.17%
1,708,187
-860,100
BCAX
56
Bicara Therapeutics
BCAX
$997M
$3.44M 0.17%
+135,000
MRSN icon
57
Mersana Therapeutics
MRSN
$49.3M
$3.43M 0.17%
+72,680
BOLD
58
Boundless Bio
BOLD
$30.7M
$2.47M 0.12%
711,329
BDTX icon
59
Black Diamond Therapeutics
BDTX
$228M
$2.2M 0.11%
506,000
ZNTL icon
60
Zentalis Pharmaceuticals
ZNTL
$107M
$1.66M 0.08%
450,000
TARA icon
61
Protara Therapeutics
TARA
$212M
$1.49M 0.07%
811,627
OBIO icon
62
Orchestra BioMed
OBIO
$179M
$1.22M 0.06%
238,193
ZURA icon
63
Zura Bio
ZURA
$209M
$1.22M 0.06%
+300,000
BCAB icon
64
BioAtla
BCAB
$48.7M
$1.21M 0.06%
686,347
MIST icon
65
Milestone Pharmaceuticals
MIST
$165M
$470K 0.02%
309,007
DBVT
66
DBV Technologies
DBVT
$464M
$175K 0.01%
50,000
NUVB.WS icon
67
Nuvation Bio Inc Warrants
NUVB.WS
$64.4M
$26.1K ﹤0.01%
266,666
SRZNW icon
68
Surrozen Inc Warrant
SRZNW
$36K
$1.33K ﹤0.01%
66,666
ABSI icon
69
Absci
ABSI
$677M
-700,000
ALLO icon
70
Allogene Therapeutics
ALLO
$273M
-3,850,000
AMLX icon
71
Amylyx Pharmaceuticals
AMLX
$1.59B
-1,500,000
ATRA icon
72
Atara Biotherapeutics
ATRA
$104M
-166,000